首页> 外文期刊>International journal of immunopathology and pharmacology. >The Effects of Captopril on Cardiac Regression, Blood Pressure and Bradykinin Components in Diabetic Wistar Kyoto Rats
【24h】

The Effects of Captopril on Cardiac Regression, Blood Pressure and Bradykinin Components in Diabetic Wistar Kyoto Rats

机译:卡托普利对糖尿病Wistar京都大鼠心脏退化,血压和缓激肽成分的影响

获取原文
       

摘要

The present study examined the left ventricular wall thickness (LVWT), total urinary kallikrein, total plasma kininogen and mean arterial blood pressure (MABP) in diabetic and non-diabetic Wistar Kyoto (WKY) rats. The MABP was significantly raised (P<0.01) in diabetic WKY rats compared to the respective controls. The LVWT was also significantly (P<0.01) increased in diabetic WKY rats than that of control WKY rats. The mean total urinary kallikrein level and the mean total plasma kininogen level were higher (P<0.01) in diabetic WKY rats, when these rats were treated with captopril (40 mg/kg and 80 mg/kg) against the mean value obtained from control WKY rats. In conclusion, this investigation suggests that diabetes induced in these rats can cause hypertension, increased LVWT and changes in the BK-forming components. Captopril treatment caused reduction in MABP, regression of LVWT and alterations in bradykinin (BK)-forming components. The possible significance of these observations is discussed.
机译:本研究检查了糖尿病和非糖尿病Wistar Kyoto(WKY)大鼠的左心室壁厚(LVWT),总尿激肽释放酶,总血浆激肽原和平均动脉血压(MABP)。与相应的对照组相比,糖尿病WKY大鼠的MABP显着升高(P <0.01)。糖尿病WKY大鼠的LVWT也显着高于对照组WKY大鼠(P <0.01)。当用卡托普利(40 mg / kg和80 mg / kg)治疗糖尿病大鼠时,糖尿病WKY大鼠的平均总尿激肽释放酶水平和平均血浆总激肽原水平较高(P <0.01) WKY大鼠。总之,这项研究表明,在这些大鼠中诱发的糖尿病可引起高血压,LVWT增加和BK形成成分的改变。卡托普利治疗引起MABP降低,LVWT消退和缓激肽(BK)形成成分改变。讨论了这些观察的可能意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号